Emergent BioSolutions Inc

NetDania - New 12 months High: Emergent BioSolutions Inc

04 Aug 2020 09:45:09 By NetDania Notify

Emergent BioSolutions Announces Proposed Offering of $400 Million of Senior Unsecured Notes

04 Aug 2020 08:00:11 By Nasdaq GlobeNewswire

NetDania - New 12 months High: Emergent BioSolutions Inc

03 Aug 2020 09:48:03 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

31 Jul 2020 09:46:27 By NetDania Notify

Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2020 and Revises Upward Full Year 2020 Guidance

30 Jul 2020 16:27:56 By Nasdaq GlobeNewswire

Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate

27 Jul 2020 06:30:10 By Nasdaq GlobeNewswire

Emergent BioSolutions Inc. to be Added to the S&P MidCap 400 Index

21 Jul 2020 16:45:10 By Nasdaq GlobeNewswire

NetDania - New 12 months High: Emergent BioSolutions Inc

20 Jul 2020 09:46:39 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

17 Jul 2020 09:53:43 By NetDania Notify

Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020

16 Jul 2020 06:30:10 By Nasdaq GlobeNewswire

NetDania - New 12 months High: Emergent BioSolutions Inc

15 Jul 2020 09:45:02 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

13 Jul 2020 11:17:29 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

09 Jul 2020 09:45:05 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

08 Jul 2020 10:01:12 By NetDania Notify

Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding

08 Jul 2020 09:00:10 By Nasdaq GlobeNewswire

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate   

06 Jul 2020 06:30:10 By Nasdaq GlobeNewswire

Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability

18 Jun 2020 06:30:10 By Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Virtual Investor Conferences

16 Jun 2020 16:05:10 By Nasdaq GlobeNewswire

Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for AstraZeneca’s COVID-19 Vaccine Candidate

11 Jun 2020 08:48:02 By Nasdaq GlobeNewswire

Emergent BioSolutions Statement on U.S. District Court Decision

05 Jun 2020 19:39:21 By Nasdaq GlobeNewswire